Production & Manufacturing
Production & Manufacturing
Novartis announces agreement to develop influenza vaccines using revolutionary...
Novartis announced today an agreement with Synthetic Genomics Vaccines Inc. (SGVI) to apply "synthetic genomics" technologies to accelerate the production of the influenza seed strains...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.